You have 9 free searches left this month | for more free features.

Elagolix E2/NETA

Showing 1 - 25 of 300

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Assess Patient-Reported Quality of Life and Effectiveness on

Recruiting
  • Heavy Menstrual Bleeding
  • Uterine Fibroids
    • Durham, North Carolina
      IQVIA RDS, Inc
    Nov 2, 2021

    Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))

    Completed
    • Heavy Uterine Bleeding
    • Uterine Fibroids
    • (no location specified)
    Jul 9, 2021

    Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)

    Completed
    • Heavy Uterine Bleeding
    • Uterine Fibroids
    • Elagolix placebo
    • +4 more
    • (no location specified)
    Jul 7, 2020

    Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))

    Not yet recruiting
    • Endometriosis
    • Moderate to Severe Endometriosis-associated Pain
    • BG2109 100mg
    • +5 more
    • (no location specified)
    Jun 6, 2023

    Sexual Dysfunction Trial (tibolone, estradiol-norethisterone)

    Completed
    • Sexual Dysfunction
    • (no location specified)
    Feb 2, 2022

    Elagolix For the Treatment of Endometriosis in Canada

    Completed
    • Endometriosis
      • Calgary, Alberta, Canada
      • +17 more
      Sep 26, 2022

      Healthy Trial in Minneapolis (Relugolix, E2/NETA)

      Completed
      • Healthy
      • Minneapolis, Minnesota
        Clinical Study Site
      Jul 20, 2021

      Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)

      Active, not recruiting
      • Heavy Menstrual Bleeding
      • Uterine Fibroids
      • Elagolix Placebo
      • +3 more
      • Birmingham, Alabama
      • +156 more
      Jan 20, 2022

      Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)

      Active, not recruiting
      • Endometriosis
      • Estradiol/Norethindrone Acetate
      • +3 more
      • Birmingham, Alabama
      • +196 more
      Feb 14, 2022

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +104 more
      Jul 9, 2021

      Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

      Active, not recruiting
      • Endometriosis
      • 75 mg linzagolix tablet
      • +5 more
      • Dothan, Alabama
      • +46 more
      Jan 12, 2023

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +123 more
      Jul 9, 2021

      Healthy Trial in Hialeah (Relugolix/E2/NETA FDC, Relugolix, Erythromycin)

      Completed
      • Healthy
      • Relugolix/E2/NETA FDC
      • +2 more
      • Hialeah, Florida
        Clinical Pharmacology of Miami, An Evolution Research Group Port
      Aug 30, 2021

      Endometriosis Trial in United States (elagolix, estradiol/norethindrone acetate (E2/NETA))

      Terminated
      • Endometriosis
      • elagolix
      • estradiol/norethindrone acetate (E2/NETA)
      • Anniston, Alabama
      • +36 more
      Nov 8, 2019

      Endometriosis Trial in Canada, Puerto Rico, United States (75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule

      Terminated
      • Endometriosis
      • 75 mg linzagolix tablet
      • +5 more
      • Little Rock, Arkansas
      • +24 more
      Dec 10, 2021

      Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

      Active, not recruiting
      • Endometriosis
      • Andalusia, Alabama
      • +168 more
      May 31, 2022

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Elagolix, Placebo for

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +95 more
      Jun 9, 2020

      Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)

      Recruiting
      • Endometriosis
      • Unexplained Infertility
      • Winston-Salem, North Carolina
        Wake Forest Univesity Health Sciences
      Dec 1, 2022

      Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)

      Completed
      • Polycystic Ovary Syndrome
      • Birmingham, Alabama
      • +53 more
      May 16, 2022

      Uterine Fibroids Trial in Puerto Rico, United States (Elagolix, Placebo)

      Completed
      • Uterine Fibroids
      • Birmingham, Alabama
      • +47 more
      Mar 4, 2022

      Infertility, Endometriosis Trial in Lone Tree (Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work)

      Recruiting
      • Infertility
      • Endometriosis
      • Elagolix 200 MG
      • +2 more
      • Lone Tree, Colorado
        Colorado Center for Reproductive Medicine
      Jul 20, 2022

      Heavy Menstrual Bleeding, Uterine Fibroid Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

      Completed
      • Heavy Menstrual Bleeding
      • Uterine Fibroid
      • Andalusia, Alabama
      • +149 more
      Jun 7, 2021

      Endometriosis Trial (Elagolix)

      Completed
      • Endometriosis
      • (no location specified)
      Jul 9, 2021